Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Cash from Operations (2016 - 2017)

Historic Cash from Operations for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to -$931700.0.

  • Bone Biologics' Cash from Operations rose 2651.39% to -$931700.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$3.3 million, marking a year-over-year increase of 5455.56%. This contributed to the annual value of -$1.2 million for FY2021, which is 18777.02% down from last year.
  • As of Q4 2017, Bone Biologics' Cash from Operations stood at -$931700.0, which was up 2651.39% from -$561035.0 recorded in Q3 2017.
  • Bone Biologics' 5-year Cash from Operations high stood at -$561035.0 for Q3 2017, and its period low was -$2.5 million during Q1 2016.